Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Cunningham

Showing results (811-820 of 1,101) with videos related to

Pageof 111
Sort By:
European Journal of Cancer (Oxford, England : 1990)|December 1, 1995
Squamous oesophageal cancer can be downstaged using protracted venous infusion of 5-fluorouracil with epirubicin and cisplatin (ECF)H J Andreyev, A R Norman, D Cunningham, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1996
'Tomudex' (ZD1694): a novel thymidylate synthase inhibitor with clinical antitumour activity in a range of solid tumours. 'Tomudex' International Study GroupD Cunningham, J Zalcberg, I Smith, et al.
Clinical Radiology|February 18, 2022
Radiology of Castleman disease: the pivotal role of imaging in diagnosis, staging, and response assessment of this rare entityF Din, F Mellor, T Millard, et al.
Faraday Discussions|July 13, 2006
Practical control of SERRS enhancementD Cunningham, R E Littleford, W E Smith, et al.
British Journal of Obstetrics and Gynaecology|September 1, 1984
Treatment of advanced ovarian cancer with combination chemotherapy using cyclophosphamide, adriamycin and cis-platinumR Milsted, G Sangster, S Kaye, et al.
British Journal of Cancer|September 1, 1993
EPIC: an effective low toxicity regimen for relapsing lymphomaT Hickish, A Roldan, D Cunningham, et al.
British Journal of Haematology|February 15, 2002
An oxaliplatin-based chemotherapy in patients with relapsed or refractory intermediate and high-grade non-Hodgkin's lymphomaI Chau, A Webb, D Cunningham, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1991
Beta-lactam antibiotics potentiate magainin 2 antimicrobial activity in vitro and in vivoR P Darveau, M D Cunningham, C L Seachord, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|September 1, 1992
Efficacy of twice daily versus three times daily oral ondansetron in the prevention of chemotherapy induced emesis: a randomized, single-blind, multicentre study. The Ondansetron International Emesis Study GroupM A Dicato, S Kaasa, E Campora, et al.
European Journal of Cancer (Oxford, England : 1990)|May 9, 2003
A randomised study of protracted venous infusion of 5-fluorouracil (5-FU) with or without bolus mitomycin C (MMC) in patients with carcinoma of unknown primaryL Assersohn, A R Norman, D Cunningham, et al.
Pageof 111

Showing results (811-820 of 1,101) with videos related to

Sort By:
Pageof 111
European Journal of Cancer (Oxford, England : 1990)|December 1, 1995
Squamous oesophageal cancer can be downstaged using protracted venous infusion of 5-fluorouracil with epirubicin and cisplatin (ECF)H J Andreyev, A R Norman, D Cunningham, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1996
'Tomudex' (ZD1694): a novel thymidylate synthase inhibitor with clinical antitumour activity in a range of solid tumours. 'Tomudex' International Study GroupD Cunningham, J Zalcberg, I Smith, et al.
Clinical Radiology|February 18, 2022
Radiology of Castleman disease: the pivotal role of imaging in diagnosis, staging, and response assessment of this rare entityF Din, F Mellor, T Millard, et al.
Faraday Discussions|July 13, 2006
Practical control of SERRS enhancementD Cunningham, R E Littleford, W E Smith, et al.
British Journal of Obstetrics and Gynaecology|September 1, 1984
Treatment of advanced ovarian cancer with combination chemotherapy using cyclophosphamide, adriamycin and cis-platinumR Milsted, G Sangster, S Kaye, et al.
British Journal of Cancer|September 1, 1993
EPIC: an effective low toxicity regimen for relapsing lymphomaT Hickish, A Roldan, D Cunningham, et al.
British Journal of Haematology|February 15, 2002
An oxaliplatin-based chemotherapy in patients with relapsed or refractory intermediate and high-grade non-Hodgkin's lymphomaI Chau, A Webb, D Cunningham, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1991
Beta-lactam antibiotics potentiate magainin 2 antimicrobial activity in vitro and in vivoR P Darveau, M D Cunningham, C L Seachord, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|September 1, 1992
Efficacy of twice daily versus three times daily oral ondansetron in the prevention of chemotherapy induced emesis: a randomized, single-blind, multicentre study. The Ondansetron International Emesis Study GroupM A Dicato, S Kaasa, E Campora, et al.
European Journal of Cancer (Oxford, England : 1990)|May 9, 2003
A randomised study of protracted venous infusion of 5-fluorouracil (5-FU) with or without bolus mitomycin C (MMC) in patients with carcinoma of unknown primaryL Assersohn, A R Norman, D Cunningham, et al.
Pageof 111